Keywords: IS Pharma, Variquel, Aloxi, Cryogesic, Aequasyal

Variquel key to IS Pharma’s growth, says Edison

Article | 19 January 2010

The success of UK speciality hospital medicines company IS Pharma is dependent on its key product, Variquel (terlipressin), used in the treatment if oesophageal bleeding in liver patients and which is being launched across the European Union, note analysts at Edison Investment Research.

Following its early approval, Variquel had its launch brought forward. Enjoying this artcle? To continue reading you need to login, take a FREE trial or subscribe.

30 day FREE trial

Sign up in less than 60 seconds! No payment needed.

Want to read the full article?
Take a 30 day FREE Trial

Take a no obligations 30 day trial.
Only one trial per user. Find out more details

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in